Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell lymphoma

OBJECTIVES: While anthracycline-based treatment can cure diffuse large B-cell lymphoma, most patients over age 80 do not receive doxorubicin due to toxicity concerns. This study evaluated this practice, as patients age 80 and older are largely excluded from clinical trials. The primary outcome of in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Geriatr Oncol
Autors principals: Carson, Kenneth R., Riedell, Peter, Lynch, Ryan, Nabhan, Chadi, Wildes, Tanya M., Liu, Weijian, Ganti, Arun, Roop, Ryan, Sanfilippo, Kristen M., O'Brian, Katiuscia, Liu, Jingxia, Bartlett, Nancy L., Cashen, Amanda, Wagner-Johnston, Nina, Fehniger, Todd A., Colditz, Graham A.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4605388/
https://ncbi.nlm.nih.gov/pubmed/25614297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jgo.2015.01.003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars